Early experience with Watson for Oncology: a clinical decision-support system for prostate cancer treatment recommendations.
Journal:
World journal of urology
Published Date:
Apr 25, 2020
Abstract
PURPOSE: Urological oncologists have difficulty providing optimal personalized care due to rapid alterations in scientific research results, medical advancements, and treatment guidelines. IBM's Watson for Oncology (WFO) is an artificial intelligence clinical decision-support system that assists oncologists with evidence-based treatment recommendations. In the present study, we examined the level of concordance between the treatment recommendations for prostate cancer according to WFO and the actual treatments that the patients received in the department of urology.